Canurta Journal

A collection of news, scientific papers and impact across industry, academia and events.

Canurta’s Research at the ALS/MND Symposium

On December 7, 2024, Canurta Therapeutics participated in the 35th International Symposium on ALS/MND, hosted by the Motor Neurone...

Jan 22

Canurta Therapeutics is pleased to share that CEO Akeem Gardner participated in the ACT (Accelerating Clinical Trials) Canada Consortium...

Oct 10, 2024

This week, I had the opportunity to attend the ALS Drug Development Summit in Boston, an event that brought together the brightest minds...

May 24, 2024